CardiologyADVANTAGE AFContinuous ECG Monitoring
ADVANTAGE AF Phase 2: Evaluating Pulsed Field Ablation for Persistent Atrial Fibrillation Using Continuous ECG Monitoring
By MedXY|Oct 3, 2025
The ADVANTAGE AF Phase 2 study demonstrates pulsed field ablation’s safety and efficacy for persistent atrial fibrillation, introducing continuous cardiac monitoring to better assess arrhythmia burden and outcomes over one year.